6 related news articles for Archived: Chronic obstructive pulmonary disease (COPD)

A new class of anti-inflammatory drug is opening a world of possibilities for treating everything from neurological diseases to cancers.…  Read more

Researchers are closer than ever to being able to turn off the actions of the immune system that damage the lungs – opening up the possibility of slowing emphysema development.…  Read more

A naturally occurring molecule found in soy products could hold the clue to a new class of potent anti-inflammatory drugs, targeting diseases ranging from heart conditions to COVID-19.…  Read more

Hudson Institute scientists have paved the way to potentially test new treatments for chronic obstructive pulmonary disease (COPD) and emphysema, following a discovery of the molecular drivers of these lung diseases.…  Read more

Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).…  Read more

Lung cancer and emphysema could be diagnosed earlier and targeted with an existing drug, vastly improving patient outcomes, researchers at Hudson Institute of Medical Research have discovered…  Read more